Technical resources / Analytical strategy

Building an impurity-control strategy for complex peptide APIs

Start from how the molecule is made, then choose complementary methods that can see the failure modes that matter.

Analyst comparing peptide impurity chromatograms with sample vials
Analytical review connects chromatographic evidence, sample identity, methods, and batch records.
Audience
Procurement, CMC, analytical, and quality teams
Resource type
LUMIRABIO technical article
Focus
Analytical strategy
01

Build a molecule and process risk map

Identify plausible deletion, insertion, truncation, epimeric, oxidation, deamidation, aggregation, adduct, and conjugation-related variants. Map each risk to the operation that can create or enrich it and to the point where it can be detected or controlled.

02

Use orthogonal methods for different questions

RP-HPLC may provide the main purity and related-substance view, while LC-MS supports identity and mass assignment. Other approaches may be required when closely related species are not adequately resolved by the primary method.

03

Let specifications evolve with knowledge

Early development limits may be broader. As route knowledge, batch history, method capability, stability data, and regulatory context grow, the specification can become more discriminating and better justified.

04

Design for method lifecycle and transfer

Record sample preparation, system suitability, integration rules, reference standards, known interferences, robustness findings, and unresolved limitations. Transfer readiness depends on reproducing analytical intent, not merely copying a procedure.

Discuss the product and analytical decision in scope.

Applicable product, method, sample, batch, and issuer records govern the final review.

Start a technical inquiry